Correlation Between LumiraDx and BioAffinity Technologies,
Can any of the company-specific risk be diversified away by investing in both LumiraDx and BioAffinity Technologies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LumiraDx and BioAffinity Technologies, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LumiraDx and bioAffinity Technologies,, you can compare the effects of market volatilities on LumiraDx and BioAffinity Technologies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LumiraDx with a short position of BioAffinity Technologies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of LumiraDx and BioAffinity Technologies,.
Diversification Opportunities for LumiraDx and BioAffinity Technologies,
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between LumiraDx and BioAffinity is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding LumiraDx and bioAffinity Technologies, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on bioAffinity Technologies, and LumiraDx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LumiraDx are associated (or correlated) with BioAffinity Technologies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of bioAffinity Technologies, has no effect on the direction of LumiraDx i.e., LumiraDx and BioAffinity Technologies, go up and down completely randomly.
Pair Corralation between LumiraDx and BioAffinity Technologies,
Given the investment horizon of 90 days LumiraDx is expected to under-perform the BioAffinity Technologies,. But the stock apears to be less risky and, when comparing its historical volatility, LumiraDx is 1.18 times less risky than BioAffinity Technologies,. The stock trades about -0.08 of its potential returns per unit of risk. The bioAffinity Technologies, is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 305.00 in bioAffinity Technologies, on August 26, 2024 and sell it today you would lose (183.00) from holding bioAffinity Technologies, or give up 60.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 31.99% |
| Values | Daily Returns |
LumiraDx vs. bioAffinity Technologies,
Performance |
| Timeline |
| LumiraDx |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| bioAffinity Technologies, |
LumiraDx and BioAffinity Technologies, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with LumiraDx and BioAffinity Technologies,
The main advantage of trading using opposite LumiraDx and BioAffinity Technologies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LumiraDx position performs unexpectedly, BioAffinity Technologies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies, will offset losses from the drop in BioAffinity Technologies,'s long position.| LumiraDx vs. Fonar | LumiraDx vs. Burning Rock Biotech | LumiraDx vs. Sera Prognostics | LumiraDx vs. Exagen Inc |
| BioAffinity Technologies, vs. Eliem Therapeutics | BioAffinity Technologies, vs. HCW Biologics | BioAffinity Technologies, vs. Scpharmaceuticals | BioAffinity Technologies, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |